The contributions of peptide antigen affinity for TCR in driving T cell memory is unclear. Effector CD4 T cells must recognize cognate antigen again at an effector checkpoint, 5-8 days post-infection, to generate an optimal memory population. In this thesis, we examined whether peptide affinity for the TCR of effectors impacts the extent of memory and degree of protection against rechallenge. We used an influenza A virus (IAV) nucleoprotein (NP)-specific TCR transgenic strain, FluNP, and generated NP- peptide variants that bind FluNP TCR with a broad range of avidity. Varying peptide avidity in vivo at the effector checkpoint revealed that higher affinity interactions yielded greater numbers of FluNP memory cells in the spleen and most dramatically in the lung and dLN. The major impact of avidity was on memory cell number, not cytokine production, and was already apparent within several days of transfer. These memory cells demonstrated enhanced protection against lethal IAV infection with a robust early day 5 secondary effector response in the lung. We previously showed that autocrine IL-2 production during the effector checkpoint prevented default effector apoptosis and supported memory formation. Here, peptide avidity determined the level of IL-2 produced by effectors while IL-2R expression was unaffected. However, IL-2Ra expression by APC drove more memory cell formation, suggesting that transpresentation of IL-2 by APC at this checkpoint enhanced CD4 memory generation. Secondary memory generation was also avidity-dependent. We propose this pathway selects CD4 effectors of highest affinity to progress to memory and can instruct future vaccine design.

Immunotherapy has emerged as a current and future paradigm of cancer treatment, which utilizes the body’s immune system to eradicate cancer. Natural Killer (NK) cells as part of the innate immune system have immense potential in their anti-tumor cytotoxic activities and host cell surveillance properties. NK cells comprise approximately five to fifteen percent of peripheral blood lymphocytes and can be proliferated in vitro using recently developed methods with co-cultures with feeder cells (derived from engineered tumor cells) or plasma membrane (PM) particles, produced from the fore mentioned feeder cells, in combination with soluble cytokines. For efficient growth and maintenance of these NK cells, Interleukin-2 (IL-2) is utilized. IL-2 in solution, through receptor mediated signaling, stimulates proliferation of T-cells and NK cells. NK cells have lower responsiveness to IL-2 and consequently require a larger systemic dose to stimulate them as opposed to competing cell populations that have higher expression of receptors for IL-2, such as T-cells, which can have the effect of lower effective stimulation of NK cell growth. Such difference in the stimulatory capability of IL-2 toward NK cells and the short circulation lifetime of soluble IL-2 require higher dosages of soluble IL-2 for effective in vivo NK cell proliferation for therapeutic application against cancer, but is toxic. Therefore establishing another form of IL-2 delivery that improves its specific targeting to NK cells would be beneficial and may be crucial for novel therapeutic improvement. The Copik Laboratory has made an IL-2 fusion protein construct having a membrane anchor for expression of membrane-bound IL-2 on K562-41bbl-21 cells (K562-IL21). K562-IL21 cells are selectively recognized by NK cells and stimulate their proliferation and cytotoxicity. Hence, a K562-IL21 membrane–bound IL-2 form should be targeted to NK cells with IL-2 delivery. K562-IL21-2 cells were then used to prepare PM21-2 particles which have the potential to provide NK cell targeted, long-lived form of IL-2 for use as an injectable drug for in vivo adjuvant stimulation of NK cells. The presence of IL-2 on the in the PM21-2 particle product was verified by Western blot, and ELISA. Particle preparations from the modified K562 cells should possess characteristics that allow them to possibly replace soluble IL-2 and more specifically increase the numbers or anti-tumor activity of NK cell populations. The effect of PM21-2 particles was studied in in vitro culture based experiments, which tested the effectiveness the PM21-2 particles to induce selective NK cells expansion as compared to PM21 particles in the presence or absence of soluble IL-2.

La vaccination muqueuse est un moyen efficace de lutter contre les pathogènes qui utilisent les muqueuses comme porte d’entrée. Cependant, la vaccination muqueuse avec des antigènes non réplicatifs nécessite l’utilisation d’adjuvants. Les molécules de la famille de la toxine du choléra, l’entérotoxine thermolabile d’E.coli (LT), la toxine du choléra (CT) ainsi que le mutant LT-R192G et les sous-unités B non toxiques de ces toxines (LTB et CTB) ont été montrées augmenter les réponses immunitaires contre des antigènes coadministrés par voie muqueuse. Cependant leur mécanisme d’action est complexe et reste encore mal connu et des différences entre molécules entières et sous-unités B ont été rapportées ainsi que, pour une même molécule, des différences selon le modèle utilisé. Dans ce travail, nous avons étudié les effets de ces cinq molécules sur les réponses anticorps ainsi que sur les lymphocytes T CD4 dans un modèle murin d’immunisation intrarectale avec des pseudoparticules virales de rotavirus (VLP-2/6). Chez les souris non immunisées, nous avons montré que ces molécules, à l’exception de la CTB, diminuent in vitro les lymphocytes T régulateurs naturels CD4+CD25+Foxp3+, probablement par un mécanisme d’apoptose. Chez les souris immunisées, toutes les molécules étudiées induisent une même réponse anticorps sérique et fécale spécifique des VLP-2/6, qu’il s’agisse des molécules entières connues pour leur fort pouvoir adjuvant ou des sous-unités B qui, elles, ont été rapportées avoir un plus faible effet adjuvant voire un effet tolérogène dans certaines études. Concernant la réponse T CD4, les réponses spécifiques de l’antigène et de l’adjuvant ont été analysées. Des différences importantes ont été mises en évidence entre ces molécules. Notamment, seules les molécules entières (LT, LT-R192G et CT) induisent la production d’IL-2 et l’activation de lymphocytes T CD4+CD25+Foxp3- mémoires spécifiques de l’antigène tout en permettant la mise en place d’une régulation médiée par des lymphocytes T régulateurs CD4+CD25+Foxp3+ (boucle d’autorégulation), qui pourraient jouer un rôle majeur lors d’une réponse secondaire, afin d’éviter les réactions inflammatoires délétères. Malgré ces différences, toutes les molécules étudiées induisent la production d’IL-17, suggérant le rôle majeur de cette cytokine dans l’effet adjuvant.L’influence de la voie d’administration sur ces effets est en cours d’étude grâce à la comparaison avec la voie intranasale / Mucosal immunization is an important goal of vaccine development to protect against pathogens that use mucosa as portals of entry. However, the use of non-replicating antigens requires the addition of adjuvants.Cholera-like enterotoxins, cholera toxin (CT) from Vibrio cholerae and the heat-labile enterotoxin (LT) from toxinogenic strains of E. coli, as well as the mutant LR-192G and their B subunits (CTB and LTB) have been shown to increase immune responses against unrelated co-administered antigens by mucosal routes. However, their mechanism of action is very complex and not completely understood and differences exist between holotoxins and B subunits and within molecules, differences exist between the models used.In this work, we have studied the effects of these five molecules on antibody responses and on CD4+ T cell responses in a murine model of intrarectal immunization using rotavirus-like particles (2/6-VLP). In non-immunized mice, we have shown that all molecules, except CTB, decreased CD4+CD25+Foxp3+ natural regulatory T cells, probably by induction of apoptosis.In immunized mice, all molecules induced similar VLP-2/6 specific systemic and fecal antibody responses, teither he holotoxins, which are well known for their strong adjuvanticity or their B subunits with a less strong adjuvanticity but with also a tolerogenic effect in some studies.Regarding the CD4+ T cell response, antigen- and adjuvant- specific responses have been analysed. Important differences have been highlighted between the molecules. Among others things, only whole toxins (LT, LT-R192G and CT) trigger IL-2 production and activation of antigen specific memory CD4+CD25+Foxp3- T cells and at the same time antigen specific CD4+CD25+Foxp3+ regulatory T cells are activated which may control the effector response (Feedback loop regulation) and avoid deleterious inflammation. In spite of these differences, all studied molecules triggered IL-17 production, suggesting the major role of this cytokine in adjuvanticity. We are currently comparing the intrarectal and intranasl routes in order to evaluate the role played by the route of immunisation in different effects of these molecules

Die Entzündungsreaktion der Arthrose wird als eine sekundäre Reaktion auf einen degenerativen Prozeß des Gelenkknorpels angesehen. Die Ursache für die Degeneration kann im Mißverhältnis zwischen Belastbarkeit und Beanspruchung liegen, es können metabolische Störungen (Urämie, Diabetes mellitus) verantwortlich gemacht werden, weswegen von sekundärer Arthrose gesprochen wird. Die Ursache der primären Arthrose bleibt unbekannt. Es kann als bewiesen angesehen werden der Zusammenhang mit Alter und Geschlecht der Patienten, denn Arthrose ist in der Regel eine Erkrankung jenseits des fünfzigsten Lebensjahres und betrifft vornehmlich Frauen. In der vorliegenden Arbeit wurde die Synovialis von 20 Patienten aufgearbeitet und hinsichtlich des enthaltenen entzündlichen Infiltrates untersucht. Unter Anwendung der indirekten Immunperoxidase Technik und der indirekten Immunfluoreszenz Technik wurde die Expression der Antigene CD 20, CD 23, CD 40, CD 27, IgG, IgA, IgM, Kappa, Lambda, CD 3, CD 4, CD 8, Ki M4, CD 68, Ki 67 sowie die Expression der Cytokine IL 2 und IL 10 analysiert. Die Synovialmembran zeigte histologisch eine Verbreiterung der Deckzellschicht, Knorpelfragmente innerhalb der Synovialmembran und ein insgesamt schwach ausgeprägtes entzündliches Infiltrat. In lediglich drei von 20 Fällen fand sich eine stärkere entzündliche Infiltration. Diese entzündlichen Infiltrate wiesen eine perivaskuläre Verteilung auf. Am häufigsten wurden in gefäßnahen Regionen B Lymphozyten identifiziert, Plasmazellen wiesen in der Regel einen deutlich größeren Abstand zum Gefäß auf. Unter den nachgewiesenen Plasmazellen fand sich eine prädominante Expression an IgG bei ausgewogener Anwesenheit sowohl der Kappa- als auch der Lambda- Leichtketten. T Lymphozyten waren ebenfalls zirkulär um die Gefäße anzutreffen und zeigten eine prädominante Interleukin 10 Expression. Lymphozytäre Aggregate, mit follikelähnlicher Struktur ließen sich in lediglich in 4 von 20 Fällen nachweisen. Makrophagen waren sowohl perivaskulär als auch in der Deckzellschicht nachweisbar. Ki M4 positive Retikulumzellen (FDC) waren dagegen nur in einem von 20 Fällen nachweisbar. Alle Zellpopulationen der Membrana synovialis wiesen nur eine schwache Proliferationsaktivität auf. Das Fehlen von dem Keimzentrum des Lymphfollikels vergleichbaren Strukturen, die deutliche Abwesenheit von Ki M4 positiver FDC's sowie die schwache Expression von Ki 67, sprechen trotz Anwesenheit der ebenfalls zur Antigenpräsentation befähigten Makrophagen gegen eine Einwanderung und Maturation nativer B Lymphozyten in die Membrana Synovialis. Wandern dagegen Gedächtniszellen in die Membrana synovialis ein, so ist eine Maturation mit Follikelbildung nicht mehr notwendig. Unter der Mithilfe von T Lymphozyten und Makrophagen können die B Lymphozyten zu Plasmazellen differenzieren. T Lymphozyten zeichnen sich ebenfalls durch eine starke perivaskuläre Verteilung aus. Dabei ist die Expression von IL 10 prädominant, was sich als eine Immunantwort von TH2-Typus interpretieren läßt. Diese ermöglicht eine Differenzierung der B Lymphozyten zu Plasmazellen. Reife B Lymphozyten, die unter dem Einfluß einer TH2 Subpopulation von CD 4 positiven T Lymphozyten ohne Keimzentrum zu Plasmazellen differenzieren, könnten ein Grund dafür sein, daß follikuläre Strukturen fehlen. Vorgereifte B Lymphozyten benötigen auch keine inflammatorisch hochpotenten Zytokine um eine schnelle Reifung und eine Immunantwort zu ermöglichen. Dies könnte ein Grund sein, warum die entzündliche Reaktion bei Arthrose so schwach ausgeprägt ist. / Inflammation in osteoarthritis is a secondary reaction to a degenerating process of the articular cartilage. Cause of Degeneration can be a disproportion of mechanical stress and resistance or metabolic diseases like diabetes mellitus. This kind of osteoarthritis is called "secondary osteoarthritis". Primary osteoarthritis has an unknown cause. Age and sex of the patient are a predictor for osteoarthritis, hense it is a disease of people above the age of 50 and more often it is found in women than in men. This paper investigated the synovial membranes of twenty patients to characterize the inflammatory Infiltrate. It characterized the cell surface antigen CD 20, CD 23, CD 40, CD 27, CD 3, CD 4, CD 8, Ki M4, CD 68, the antibodies IgG, IgA, IgM, Kappa, Lambda, the proliferating antigen Ki 67 and the expression profile of the cytokines IL 2 and IL 10 by using immunohistochemical staining (indirect immunoperoxidase technique and indirect immunofluorescence technique) with monoclonal antibodies. The synovial membrane shows in histology a dissemination of cover cells, fragments of cartilage and a slight expression of inflammatory infiltrate with a perivascular allocation. In only three of twenty cases we detected stronger inflammatory infiltrates. Most of the perivascular cells express CD 20. They are B lymphocytes. Plasma cells have more distance to the blood vessels and showed a predominant expression of IgG. T-lymphocytes were also detected perivascular. The expression of IL 10 was predominant. Lymphocytes aggregates like lymph follicle were detected in four of twenty cases. Macrophages were proved perivascular as well as in the cover cells. Ki M4 positive reticulum cells were found in only one of twenty cases. All kind of cells in the synovial membrane showed a low proliferation activity. The absence of germinal centers or comparable structures, the low expression of Ki M4 and Ki 67 speak against the immigration and maturation of native B lymphocytes in the synovial membrane. Memory B-lymphocytes don't need germinal centers or compatible structures for maturation, they can mature to plasma cells by help of T-lymphocytes, macrophages or other B-lymphocytes. It is more probably that the detected B lymphocytes are memory cells. The perivascular T lymphocytes in combination with the predominant expression of IL 10 may be interpreted as a TH2 immune reaction. This supports the maturation of B-lymphocytes to plasma cells. The maturation of memory B-lymphocytes under influence of TH2 immune reaction can be the reason for the missing of germinal centers or comparable structures. Matured B-lymphocytes don't need high-grade inflammatory cytokines for quick immune response. This is the possible reason for the low-grade inflammatory reaction of osteoarthritis.

Tumor diseases are severe problem worldwide with increasing number of patients suffering from various types of malignancies. Many of approved therapeutics cause serious side toxicities. Therefore, there are intensive efforts to improve cancer treatment protocols. The aim of this study was to deplete regulatory T (Treg) cells without affecting other immunocompetent cells playing a positive role in tumor eradication. Treg cells were reported to hamper anti-tumor immunity and promote tumor growth and survival. Thus, their selective elimination could lead to induction of anti-tumor responses and tumor rejection if combined with chemotherapy with selected N-(2- hydroxypropyl)methacrylamide (HPMA) copolymer-bound drug conjugates. Original approach was to deplete of Treg cells without the use of anti-CD25 mAb that has been widely exploited for Treg cell elimination; however, its long-term persistence in circulation together with inhibitory effect on activated effector cells (CD25+ ) are its main disadvantages. Thus, Treg cells were sensitized to cell cycle-specific cytostatic drugs via application of IL-2/anti-IL-2 JES6.1 mAb immunocomplexes that induce vigorous selective proliferation of this cell population. Subsequent application of cell cycle-specific cytostatics showed steep decrease of Treg cell...

Des études récentes ont montré une implication de la neuropiline 1 (Nrp1)dans le contrôle de l’activation des lymphocytes T. Son invalidation s’accompagne d’une aggravation de l’encéphalite auto-immune expérimentale (EAE). La sémaphorine 3A (Sema-3A), ligand principal de la Nrp1, semble participer à une boucle autocrine de rétro contrôle négatif de la prolifération des lymphocytes T.Cependant, peu d’études ont été réalisées chez l’homme pour déterminer dans quelle(s) situation(s) la Nrp1 est exprimée par les lymphocytes T. Notre travail aconsisté à étudier l’expression de la Nrp1 par les populations lymphocytaires T humaines afin de comprendre à quel niveau peut avoir lieu ce rétro contrôle. Nous montrons que les lymphocytes T régulateurs (Treg) chez l’homme n’expriment pas laNrp1, contrairement aux Treg murins. En revanche, la Nrp1 est exprimée par les lymphocytes T effecteurs après engagement avec l’antigène, soit au niveau des organes lymphoïdes secondaires pour les lymphocytes T folliculaires helper (Tfh) en interaction avec les lymphocytes B, soit au niveau des sites d’inflammations périphériques pour les lymphocytes T effecteurs mémoires (TEM). Dans les deux cas, cette expression survient en fin d’activation et pourrait servir de frein à une activation incontrôlée des lymphocytes T.D’autre part, nous avons abordé le rôle du récepteur alpha à l’IL-2 (CD25)dans l’homéostasie des lymphocytes T. L’étude chez la souris il2ra-/- a révélé un rôle important du CD25 pour la survie des Treg in vivo, mais aussi pour l’acquisition de lymphocytes T mémoires. Seulement deux cas de déficience en CD25, associés à des maladies auto-immunes, ont été décrits chez l’homme. Cependant, ces études n’ont pas abordé à quel niveau le CD25 intervient sur l’homéostasie des lymphocytes T. Nous complétons ces études par la présentation de trois nouveaux cas de déficience en CD25 développant des maladies auto-immunes de type IPEX. Nous montrons que le CD25 intervient activement dans le maintien des populations Treg naïves et effectrices, mais aussi dans celui des populations lymphocytaires effectrices mémoires. / Recent studies have shown the involvement of neuropilin 1 (Nrp1) in the control of T cell activation, and disruption of this receptor promotes aggravation of experimental autoimmune encephalitis (EAE). Through its principal ligand,semaphorin 3A (Sema-3A), Nrp1 appears to participate in an autocrine negative feedback of T cell proliferation. However, few studies have been conducted inhumans to determine when Nrp1 is expressed by T cells. Here we show that regulatory T cells (Treg) in humans do not express Nrp1, unlike murine Treg cells. In contrast, we show that Nrp1 is expressed by effector T cells after engagement with antigen, either in secondary lymphoid organs for follicular helper T cells (Tfh) interacting with B cells, either in peripheral inflammation for effector memory T cells(TEM). We conclude that this expression corresponds to a level of late activation in both cases and may control T cell activation.The study in mice il2ra-/- revealed a significant role of IL-2 receptor alpha(CD25) for the survival of Treg in vivo, but also for the differentiation of memory T cells. Only two cases of CD25 deficiency associated with autoimmune diseases have been described in humans. However, these studies do not assess at what levelCD25 is involved in T cell homeostasis. Here we provide further insight of these studies by presenting three new cases of CD25 deficiency developing autoimmune diseases like IPEX. We show that CD25 plays an active role to maintain naive and effector Treg cell populations of, and effector memory T cell populations.

<p>Stimulation of the T cell receptor (TCR) induces tyrosine phosphorylation of numerous intracellular proteins, leading to activation of the interleukin-2 (IL-2) gene in T lymphocytes. Shb is a ubiquitously expressed adapter protein, with the ability to associate with the T cell receptor and several signaling proteins in T cells, including: the TCR ζ-chain, LAT, PLC-γ1, Vav, SLP-76 and Gads. Jurkat T cells expressing Shb with a mutation in the SH2 domain, exhibited reduced phosphorylation of several proteins and abolished activation of the MAP kinases ERK1, ERK2 and JNK, upon CD3 stimulation. The TCR induced Ca²⁺ response in these cells was abolished, together with the activation of the IL-2 promoter via the transcription factor NFAT. Consequently, IL-2 production was also perturbed in these cells, compared to normal Jurkat T cells. Shb was also seen to associate with the β and γ chains of the IL-2 receptor, upon IL-2 stimulation, in T and NK cells. This association occurred between the Shb SH2 domain and Tyr-510 of the IL-2R β chain. The proline-rich domains of Shb were found to associate with the tyrosine kinases JAK1 and JAK3, which are important for STAT-mediated proliferation of T and NK cells upon IL-2 stimulation. Shb was also found to be involved in IL-2 mediated regulation of apoptosis. These findings indicate a dual role for Shb in T cells, where Shb is involved in both T cell receptor and IL-2 receptor signaling. </p><p>A Shb homologue, Shf was identified, and seen to associate with the PDGF-α-receptor. Shf shares high sequence homology with Shb and a Shd (also of the Shb family) in the SH2 domain and in four motifs containing putative tyrosine phosphorylation sites. When Shf was overexpressed in fibroblasts, these cells displayed significantly lower rates of apoptosis than control cells in the presence of PDGF-AA. These findings suggest a role for the novel adapter Shf in PDGF-receptor signaling and regulation of apoptosis.</p>

Stimulation of the T cell receptor (TCR) induces tyrosine phosphorylation of numerous intracellular proteins, leading to activation of the interleukin-2 (IL-2) gene in T lymphocytes. Shb is a ubiquitously expressed adapter protein, with the ability to associate with the T cell receptor and several signaling proteins in T cells, including: the TCR ζ-chain, LAT, PLC-γ1, Vav, SLP-76 and Gads. Jurkat T cells expressing Shb with a mutation in the SH2 domain, exhibited reduced phosphorylation of several proteins and abolished activation of the MAP kinases ERK1, ERK2 and JNK, upon CD3 stimulation. The TCR induced Ca2+ response in these cells was abolished, together with the activation of the IL-2 promoter via the transcription factor NFAT. Consequently, IL-2 production was also perturbed in these cells, compared to normal Jurkat T cells. Shb was also seen to associate with the β and γ chains of the IL-2 receptor, upon IL-2 stimulation, in T and NK cells. This association occurred between the Shb SH2 domain and Tyr-510 of the IL-2R β chain. The proline-rich domains of Shb were found to associate with the tyrosine kinases JAK1 and JAK3, which are important for STAT-mediated proliferation of T and NK cells upon IL-2 stimulation. Shb was also found to be involved in IL-2 mediated regulation of apoptosis. These findings indicate a dual role for Shb in T cells, where Shb is involved in both T cell receptor and IL-2 receptor signaling. A Shb homologue, Shf was identified, and seen to associate with the PDGF-α-receptor. Shf shares high sequence homology with Shb and a Shd (also of the Shb family) in the SH2 domain and in four motifs containing putative tyrosine phosphorylation sites. When Shf was overexpressed in fibroblasts, these cells displayed significantly lower rates of apoptosis than control cells in the presence of PDGF-AA. These findings suggest a role for the novel adapter Shf in PDGF-receptor signaling and regulation of apoptosis.

The goal of this body of research was to elucidate the mechanism by which CD4+ T cells provide help for CD8+ cytotoxic T lymphocyte (CTL) responses in different immunization types. The establishment of diseases, such as chronic infections and cancers, is attributed to severe loss of or dysfunctions of CD4+ T cells. Even in acute infections, CD4+ T cell deficiency leads to poor memory responses. While the role of CD4+ T cells is being increasingly appreciated in these diseases, the timing and nature of CD4+ T help and associated molecular mechanisms are not completely understood. Growing evidence suggests that, depending on the type of infections or immunizations, the requirements of CD4+ T cells can vary for optimal CD8+ CTL responses. In order to understand the modulatory effects of CD4+ T cells for optimal CD8+ CTL responses, two distinct immunization types were chosen. These include: 1) non-inflammatory dendritic cell (DC) immunization, which fails to provide inflammatory/danger signals; and 2) inflammatory adenovirus (AdV) immunization, which provides profound inflammatory/danger signals. This allowed us to study CD4+ T cell’s participation under different inflammatory conditions. The studies described in Chapters 2 and 3 of this thesis were performed to further understand the concept of how CD4+ T cells mediate optimal CD8+ CTL responses. This has been called the “new dynamic model of CD4+ T helper – antigen (Ag)-presenting cells (Th-APCs),” proposed in 2005 by our laboratory. The study described in Chapter 2 shows that Th-APCs participate not only in augmenting CTL-mediated immune responses, perhaps during early phase, but also in regulating cellular immunity, perhaps during a later phase. Through enhanced IL-2, CD80 and CD40L singnaling, and weaker peptideMHC I (pMHC) signaling, Th-APCs stimulated naïve CD8+ T cells to differentiate into effector CTLs, capable of developing into, central memory CTLs. Th-APC-stimulated CD4+ T cells behaved like Th cells in function, augmenting the overall magnitude of CTL responses. In contrast, Th-APCs were able to kill DCs and other Th-APCs, predominantly through perforin-mediated pathway. The experiments described in Chapter 3 revealed a novel co-operative role of cognate Th-CTL interactions, contrary to previously known immune-regulatory mechanisms among Th-Th or CTL-CTL interactions. In our experiments, Th cells, via CD40L, IL-2, and acquired pMHC-I signaling, enhanced CTL survival and transition into functional memory CTLs. Moreover, RT-PCR, flow cytometry and western blot analysis demonstrate that increased survival of Th cell-helped CTLs is matched with enhanced Akt1/NF-κB activation, down-regulation of FasL and TRAIL, and altered expression profiles with up-regulation of prosurvival (Bcl-2) and down-regulation of proapoptotic (NFATc1, Bcl-10, Casp-3, Casp-4, Casp-7) genes/ molecules. Finally, helped CTLs were also able to induce protection against highly metastasizing tumor challenge, explaining why memory CTLs generated under cognate Th1’s help show survival and recall advantages. The studies in Chapter 4 showed how the precursor frequency (PF) of CD8+ T cells impacts CD4+ T helper requirements for functional CTL responses. At endogenous PF, CD4+ T helper signals were necessary for both primary and memory CTL responses. At increased PF, CD4+ T help, and its CD40L but not IL-2 signal became dispensable for primary CTL responses. In contrast, memory CTL responses required CD4+ T cell signals, largely in the form of IL-2 and CD40L. Thus, these results could impact the development of novel immunotherapy against cancers, since their efficacy would be determined in part by CD4+ T help and CD8+ T cell PF. Finally, the study showed the importance of CD4+ T cells for multiple phases of AdV transgene product-specific CTL responses. These include: a) cognate CD4+ T cells enhanced CTL responses via IL-2 and CD40L signaling during primary, maintenance and memory phases; b) polyclonal CD4+ T environment enhanced the survival of AdV-specific CTL survival, partially explaining protracted CTL contraction phase; and c) during the recall phase, the CD4+ T environment, particularly memory CD4+ T cells, considerably enhanced not only helped, but also unhelped, memory CTL expansion. Thus, these results suggest the participation of both cognate and polyclonal CD4+ T cells for multiple phases of AdV-specific CTLs. Taken together, the current work delineated the critical roles of CD4+ T cells in different stages of CTL responses and in the development of anti-tumor immunity. The results presented here will significantly advance our current understanding of immunity to cancers, autoimmunity and chronic infections, since pathogenesis of these diseases is largely determined by CD4+ T helper functions. As most immunization procedures use the principle that is based on functions of memory cells, the knowledge gained from this work will also have a major impact on designing vaccines against intractable diseases, including cancers and chronic infections. Moreover, in advanced tumors, vaccines developed using this knowledge may act synergistically with other cancer treatments such as irradiation, chemotherapy and microsurgery, minimizing their side effects and prolonging the lives of patients.

Σκοπός της παρούσης διατριβής είναι να προτείνει ένα τυπικό πλαίσιο για μια μεθοδολογία ανάλυσης που να ενσωματώνει ποσοτικά, και λειτουργικά δεδομένα και στοχεύει στο σχεδιασμό πειραμάτων για την επιβέβαιωση μεταγραφικών παραγόντων που δεσμεύονται σε ένα λειτουργικά ενεργό μοτίβο στον υποκινητή γονιδίων. Το πλαίσιο αυτό που βασίζεται στη Bayesian πιθανοκρατική θεωρία όπως αυτή θεμελιώνεται στη θεωρία λήψης αποφάσεων, εφαρμόζεται σε ένα πρόβλημα από το ερευνητικό πεδίο της ανοσοβιολογίας. Συγκεκριμένα μελετούμε την ανίχνευση μεταγραφικών παραγόντων που ενέχονται στην αρνητική ρύθμιση της γονιδιακής έκφρασης κατά τη διαδικασία ενεργοποίσης των Τ λεμφοκυττάτων. Η υιοθέτηση του προτεινούμενου πλαισίου σμιλεύει μαι αυστηρή διαδοχή διεξαγωγής in vitro και in silico πειραμάτων που ξεκινά από τεχνικές μαζικής ανάλυσης γονιδιακής έκφρασης, περνά μέσα από βάσεις δεδομένων μεταγραφικών παραγόντων και μέσω πειραμάτων ηλεκτροφορητικής κινητικότητας (Electromobility Shift Assays) στοχεύεται στην επιβεβαίωση που προσφέρουν τα πειράματα διαμόλυνσης (transfection and reporter assays). Κατά την τυποποίηση της λογικοφανούς αυτής προσέγγισης ανακύπτει ένα από τα γνωστότερα προβλήματα της εφαρμοσμένης στατιστικής, το πρόβλημα των "δύο μέσων όρων" ή πρόβλημα Behrens-Fisher. Για τη λύση αυτού του προβλήματος προτείνονται νέα μαθηματικά εργαλεία τα οποία αξιοποίηθηκαν για την κατασκευή αντίστοιχου λογισμικού. Με την εφαρμογή αυτών των εργαλείων στο εφαρμοσμένο ανοσοβιολογικό πρόβλημα προέκυψε μια μη αναμενόμενη σχέση μεταξύ δυο φαινομενικά μη συνδεόμενων συστημάτων¨των γονιδίων των κυτταροκινών και του ιού HIV. Μέσω της περιγραφόμενης μεθοδολογίας κατέστη εφικτή μια υποθεσο-εξαρτώμενη προσέγγιση σε ένα σημαντικό πρόβλημα το οποίο δεν ήταν δυνατό να λύθέί με κλασσικές βιοχημικές τεχνικές λόγω τεχνικών δυσκολιών / The current disertation concerns the description of a formal framework and an analytic methodology which aims to validate transcription factors controlling gene expression through functional and quantitative data. This Bayesian decision theory inspired framework is applied to a specific immunobiological problem. The problem targetted was the discovery of transcriptional repressors implicated in the negative control of T cell activation. Adopting the proposed framework leads one to a staged experimental strategy which starts from high-throughput gene expression data and transcription factor databases and through Electrophoretic Mobility Shift Assays targets the design of transfection and reporter gene assays. The formalization of the proposed approach, led to one of the famous applied statistics problems i.e. the two means or Behrens - Fisher problem. In order to deal with the computational aspects of this problem, we applied a novel integral transformations and ported them to software. The application of these tools to the immunobiological problem led to an unexpected connection between two seemingly unrelated systems: cytokine gene protomers and HIV LTR. The proposed methodology enabled a hypothesis-driven approach to an important basic immunobiological problem which could not be solved by standard biochemical techniques.